CD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: a refined target for radiotherapy trials?

Cindy Lee; Barbara Guinn; Suzanne E. Brooks; Deborah Richardson; Kim H. Orchard

doi:10.1111/j.1365-2141.2010.08100.x

CD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: a refined target for radiotherapy trials?

Cindy Lee
, Barbara Guinn
, Suzanne E. Brooks
, Deborah Richardson
, Kim H. Orchard

Research output: Contribution to journal › Article › peer-review

16 Citations (Scopus)

Original language	English
Pages (from-to)	795-796
Journal	British Journal of Haematology
Volume	149
Issue number	5
DOIs	https://doi.org/10.1111/j.1365-2141.2010.08100.x
Publication status	Published - 1 Jun 2010
Externally published	Yes

Keywords

radiotherapy

Access to Document

10.1111/j.1365-2141.2010.08100.x

http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2010.08100.x/abstract

Handle.net

Persistent link

Cite this

@article{bbfd31c7bc384c2e86195ce63341908a,

title = "CD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: a refined target for radiotherapy trials?",

keywords = "radiotherapy",

author = "Cindy Lee and Barbara Guinn and Brooks, \{Suzanne E.\} and Deborah Richardson and Orchard, \{Kim H.\}",

year = "2010",

month = jun,

day = "1",

doi = "10.1111/j.1365-2141.2010.08100.x",

language = "English",

volume = "149",

pages = "795--796",

journal = "British Journal of Haematology",

issn = "0007-1048",